Illustrative image – not actual.Avon Organics plans to foray into
biotechnology with an investment of Rs.13 crore. The company plans to set up a
biotechnology project at Chincholi Industrial Area in Solapur in Maharashtra to
manufacture ephedrine and pseudo-ephedrine. The company has already received
the necessary approvals, permissions and licences for the commissioning of this
project.
According to the company, the
project is expected to be commissioned by the end of 2000.
In order to part finance this project,
the company would be issuing convertible warrants and 18 lakh privately-placed equity shares. Of the funds raised, the company would use Rs.5 crore for its
biotechnology project, while the rest would be used to augment the company’s
long-term working capital requirements. The remaining funds of Rs.8 crore
required for the project would be brought in through a term loan from ICICI.
Avon Organics would be the third company in India, after Colour Chem and Krebs Bio, to manufacture ephedrine and pseudo-ephedrine in the organised sector.
